adverse drug reactions
AERDaspirin-exacerbated respiratory disease
AGEPacute generalized exanthematous pustulosis
BATbasophil activation test
BLsbeta-lactam antibiotics
CFTRcystic fibrosis transmembrane conductance regulator
DHRdrug hypersensitivity reactions
DIAdrug-induced anaphylaxis
DIESdrug-induced enterocolitis syndrome
DIHSdrug-indued hypersensitivity syndrome
DILIdrug-induced liver injury
DRESSdrug reaction with eosinophilia and systemic symptoms
EAACIEuropean Academy of Allergy and Clinical Immunology
ELISpotEnnzyme-linked Immunosorbent Spot
ENDAEuropean Network on Drug Allergy
FPIESfood protein induced enterocolitis syndrome
GBCMgadolinium-based contrast media
GVHDgraft-versus-host disease
HLAhuman leukocyte antigen
IDHRsimmediate drug hypersensitivity reactions
LTTlymphocyte transformation test
MHCmajor histocompatibility complex
MPEmaculopapular exanthema
MRGPRX2mas-related G-protein-coupled receptor member X2
NECDNSAID-exacerbated cutaneous disease
N-ERDNSAID-exacerbated respiratory disease
NSAIDsnon-steroidal anti-inflammatory drugs
NIDHRsnon-immediate reactions
NIUAAANSAID -induced urticaria
angioedemaand anaphylaxis
NBLAnon-betalactam antibiotic
NMBAneuromuscular blocking agents
NPVnegative predictive value
nsLTPnon-specific lipid transfer protein
POHperi-operative drug allergy
PIpharmacological interaction
RDDrapid drug desensitization
RIMEreactive infectious mucocutaneous eruption
SCARssevere cutaneous adverse reactions
SJSStevens-Johnson Syndrome
SSLRserum sickness-like reactions
TENtoxic epidermal necrolysis
TMP-SMXtrimethoprim-sulfamethoxazole
WAOWorld Allergy Organization
Comments (0)